Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2014
06/04/2014CN103232438B Pantoprazole sodium and preparation method thereof
06/04/2014CN103058993B Chlorantraniliprole preparation method
06/04/2014CN102712624B Indole compound and pharmaceutical use thereof
06/04/2014CN102639526B L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
06/04/2014CN102516229B Fluorescent probe for detecting histidine, precursor thereof and preparation methods of fluorescent probe and precursor
06/04/2014CN102471313B GPR119 agonists
06/04/2014CN102459222B L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
06/04/2014CN102405218B Diamide compounds having muscarinic receptor antagonist and ss2 adrenergic receptor agonist activity
06/04/2014CN102369187B N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
06/04/2014CN102264704B Isoquinoline derivative
06/04/2014CN102212030B Substituted tetrahydrocarbazole antifungal compounds and preparation method thereof
06/04/2014CN102083797B Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/04/2014CN101861313B Phenyl amino pyrimidine compounds and uses thereof
06/03/2014US8742121 Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein
06/03/2014US8742119 Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
06/03/2014US8742117 Oxime derivatives
06/03/2014US8742100 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
06/03/2014US8742099 Compounds
06/03/2014US8742097 Triazole compounds I
06/03/2014US8741924 Compounds and methods for treatment of systemic lupus erythematosus
06/03/2014US8741916 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor
06/03/2014US8741914 Antiviral compounds and uses thereof
06/03/2014US8741894 Arylsulfonamide CCR3 antagonists
06/03/2014US8741892 Compounds
06/03/2014US8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors
06/03/2014US8741450 Material for organic electroluminescence devices and organic electroluminescence device using the material
06/03/2014CA2635015C Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
06/03/2014CA2614981C Antibacterial quinoline derivatives
06/03/2014CA2590110C Kinase modulators and method of use
06/03/2014CA2426942C 8-carboxamido-2,6-methano-3-benzazocines
05/2014
05/30/2014WO2014081816A1 Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
05/30/2014WO2014081756A1 S1p and/or atx modulating agents
05/30/2014WO2014081752A1 S1p and/or atx modulating agents
05/30/2014WO2014081697A2 Anthelmintic compounds and compositions and method of using thereof
05/30/2014WO2014081689A1 Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
05/30/2014WO2014081388A1 Dopants for solid-state dye-sensitive solar cells
05/30/2014WO2014081206A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
05/30/2014WO2014080640A1 Erythropoietin expression promoter
05/30/2014WO2014080291A2 Biaryl derivatives as bromodomain inhibitors
05/30/2014WO2014080290A2 Cyclic amines as bromodomain inhibitors
05/30/2014WO2014079995A2 Novel inhibitor compounds of phosphodiesterase type 10a
05/30/2014WO2014079953A1 SYNTHESIS OF IMIDAZO[1,2-a]PYRAZIN-4-IUM SALTS FOR THE SYNTHESIS OF 1,4,7-TRIAZACYCLONONANE (TACN) AND N- AND/OR C-FUNCTIONALIZED DERIVATIVES THEREOF
05/30/2014WO2014079504A1 Polycyclic ligands of 5-ht7 receptor and use thereof
05/30/2014WO2014079155A1 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives
05/30/2014WO2014079154A1 Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
05/30/2014WO2014043252A3 Hydroxypyridinone-,hydroxypyrimidinone-and hydroxypyridazinone drivatives and their therapeutic application
05/30/2014WO2014041559A3 Process for preparation of dabigatran etexilate and intermediates thereof
05/29/2014US20140148601 Process for the preparation of benzimidazole derivatives and its salts
05/29/2014US20140148487 Antimicrobial amphiphiles and methods for their use
05/29/2014US20140148467 Carboxamide Compounds and Methods for Using the Same
05/29/2014US20140148462 Indanyloxydihydrobenzofuranylacetic acids
05/29/2014US20140148461 Novel inhibitor compounds of phosphodiesterase type 10a
05/29/2014US20140148459 Matrix metalloproteinase inhibitors
05/29/2014US20140148458 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
05/29/2014US20140148454 Substituted amino-acrylcarboxamides as kcnq2/3 modulators
05/29/2014US20140148453 Sulfonamide compounds useful as cyp17 inhibitors
05/29/2014US20140148451 Autophagy Inhibitors
05/29/2014US20140148448 Inhibitors of c-fms kinase
05/29/2014US20140148443 Novel Imidazolines as dual inhibitors of MDM2 and MDMX
05/29/2014US20140148436 Akt protein kinase inhibitors
05/29/2014US20140148435 Azetidine and piperidine compounds useful as pde10 inhibitors
05/29/2014US20140148432 Compounds for the Treatment of Neurological Disorders
05/29/2014US20140148411 Fungicide pyrazole carboxamides derivatives
05/29/2014US20140148377 Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using Same
05/29/2014US20140147920 Specific nNOS Inhibitors for the Therapy and Prevention of Human Melanoma
05/28/2014EP2735567A1 Heterocyclic substituted pyrimidine compound
05/28/2014EP2735562A1 Estrogen receptor modulators and uses thereof
05/28/2014EP2734518A1 Novel complexing agents and corresponding lanthanide complexes
05/28/2014EP2734517A1 Benzamides
05/28/2014EP2734516A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
05/28/2014EP2734505A1 3-(fluorvinyl)pyrazoles and the use thereof
05/28/2014CN103827105A 作为胆固醇酯转移蛋白(cetp)抑制剂的取代的杂环胺化合物 As the cholesterol ester transfer protein (cetp) inhibitors substituted heterocyclic compound
05/28/2014CN103827104A 双碳环和三碳环乙炔基衍生物及其应用 Double and triple carbon-carbon cyclic ring ethynyl derivative and Applications
05/28/2014CN103827103A N-硫代邻氨基苯甲酰胺化合物及其作为农药的用途 N- thio anthranilamide compounds and their use as pesticides
05/28/2014CN103827102A 取代的吡啶甲酸和嘧啶-4-羧酸、其制备方法及其作为除草剂和植物生长调节剂的用途 Substituted pyridine and pyrimidine-4-carboxylic acid, their preparation and their use as herbicides and plant growth regulators use
05/28/2014CN103827101A 新的双环二氢喹啉-2-酮衍生物 New bicyclic derivatives of dihydro-quinolin-2-one
05/28/2014CN103827092A N-硫代邻氨基苯甲酰胺化合物及其作为农药的用途 N- thio anthranilamide compounds and their use as pesticides
05/28/2014CN103827091A 二氢吡唑、其药物组合物及其治疗生育障碍的用途 Dihydro-pyrazol-use, the pharmaceutical compositions and treatment of fertility disorders
05/28/2014CN103827090A 取代的喹啉及其作为药物的用途 Substituted quinolines and their use as medicament
05/28/2014CN103827089A 具有血管发生抑制活性的新化合物、其制备方法及包含其的药物组合物 The novel compounds having angiogenesis inhibitory activity, methods for their preparation and pharmaceutical compositions containing them
05/28/2014CN103827087A 用于制备2-[(2e)-2-氟-2-(3-亚哌啶基)乙基]-1h-异吲哚-1,3(2h)-二酮的改进方法 For the preparation of 2 - [(2e) -2- fluoro-2- (3-piperidinylidene) ethyl] -1h- isoindole -1,3 (2h) - dione improved method
05/28/2014CN103819537A 抗病毒化合物 Antiviral compounds
05/28/2014CN103819486A 标记血清糖原磷酸化酶浓度水平的光亲和标记探针分子、其制备方法及医药用途 Labeled serum levels of glycogen phosphorylase photoaffinity labeling probe molecules, their preparation and pharmaceutical use
05/28/2014CN103819470A 介离子杀虫剂 Mediated ion pesticides
05/28/2014CN103819459A 抗病毒化合物 Antiviral compounds
05/28/2014CN103819457A 一类能够抑制去势抵抗性前列腺癌和成骨转移的格尔德霉素衍生物及其应用 A class can inhibit castration-resistant prostate cancer and bone metastases into geldanamycin derivative and its applications
05/28/2014CN103819456A 一组格尔德霉素衍生物及其应用 A group of geldanamycin derivatives and their application
05/28/2014CN103819455A 新有机电致发光化合物和使用该化合物的有机电致发光设备 The new organic electroluminescent compounds and the use of the compound organic electroluminescent devices
05/28/2014CN103819454A N-(2,6-二氧代-3-哌啶基)邻苯二甲酰亚胺类化合物制备方法 N- (2,6- dioxo-3-piperidyl) phthalimide prepared compounds
05/28/2014CN103819453A 一种[Cu<sub>2</sub>(L<sup>2</sup>)<sub>2</sub>]·H<sub>2</sub>O配合物及原位合成方法 One kind of [Cu <sub> 2 </ sub> (L <sup> 2 </ sup>) <sub> 2 </ sub>] · H <sub> 2 </ sub> O composition and in situ synthesis method that
05/28/2014CN103819452A 1-(6-甲基吡啶)-5-羟基-1-氢-吡唑-3-甲酸甲酯及合成方法 1- (6-methyl-pyridine) -5-hydroxy-1 Hydrogen - pyrazole-3-carboxylate and synthetic methods
05/28/2014CN103819451A 一种制备3-甲基吲哚酮衍生物的方法 A method for the indole derivatives of methyl 3 - Preparation of
05/28/2014CN103819450A 一种苯甲酸阿格列汀的新制备方法 New method for the preparation of one kind of alogliptin benzoate
05/28/2014CN103819416A N-(3-氨基-喹喔啉-2-基)-磺酰胺衍生物及其作为磷脂酰肌醇3-激酶抑制剂的用途 N- (3- amino - quinoxalin-2-yl) - sulfonamide derivatives and their use as inhibitors of phosphatidylinositol 3-kinase use
05/28/2014CN103819413A 含喹唑啉酮芳氧基的戊二烯酮类化合物及制备方法和应用 Quinazolinone containing glutaric aryloxy enone compounds and preparation method and application
05/28/2014CN103819393A 化合物及其治疗应用 Compounds and their therapeutic applications
05/28/2014CN102690259B 具有利尿作用的化合物、其制备方法和用途 Compounds having a diuretic effect, their preparation and use
05/28/2014CN102516271B 具有三维网络结构的金属银配位聚合物及其制备方法与应用 Metallic silver coordination polymer and its preparation method and application of three-dimensional network structure
05/28/2014CN102471315B 制备4-氨基丁-2-烯羟酸内酯的方法 Methods for preparing 4-amino-2-ene-carboxylic acid lactone
05/28/2014CN102417502B 氮唑类抗真菌化合物、盐类及其制备方法和用途 Azole antifungal compounds, salts and their preparation and use
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 1080